ArticleIJID regions2026
Microbiological profiles of Gram-negative bacteria isolated from respiratory samples of mechanically ventilated patients at a tertiary Moroccan hospital.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To characterise the Gram-negative bacteria implicated in ventilator-associated pneumonia (VAP), focusing on their antimicrobial resistance profiles and phylogenetic relationships. Methods: Seventy-eight isolates were collected from protected distal samples over two years; patients were under mechanical ventilation in the three adult ICUs of a Moroccan tertiary hospital. Isolates were identified using VITEK2. PFGE and FTIR determined genetic relationships, whereas the detection of genetic resistance determinants was carried out using PCR. Results: Carbapenem-resistant Conclusion: The prevalence of MDR and XDR bacteria among VAP cases in a tertiary hospital in Morocco is increasing, potentially due to the coexistence of antimicrobial resistance genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.